In recent years, studies have reported the role of EP300 as a tumor‐promoting factor in various cancers, including CRC stomach cancer, and play an important role in the regulation of various biological processes such as activating oncogene, regulation of immune function, and tumor cell growth.77 This evidence concerns the gene EP300 and colorectal carcinoma.